mayo clinic tirzepatide New research from a Clinic–led study suggests that postmenopausal women using menopause hormone therapy may experience greater weight loss when treated with tirzepatide, a GLP-1–based medication for overweight and obesity. In How the weight loss drug

Slowing down can make meals more comfortable and help you recognize fullness sooner

"The doctor said, 'you are having an allergic reaction and you better stop it'," he said

Scientists are also looking into whether they could be used to treat depression, alcoholism, and other conditions

Otherwise, theyre considered cosmetics, so the FDA doesnt look at them, and you cant really prove that they raise GLP-1 levels. And even if they were to boost GLP-1 levels, its not at all comparable to what GLP-1 meds do, according to Yana Delkhah, MD, a board-certified emergency medicine physician and longevity and functional medicine practitioner

That dose-dependent curve is exactly why titration-based strategies work